Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1984-6-11
|
pubmed:abstractText |
Twelve patients with relapsing-remitting multiple sclerosis and 3 control subjects were evaluated weekly for six months. Peripheral blood lymphocyte subsets were enumerated using monoclonal antibodies and analysis with a dual-laser fluorescence-activated cell sorter. Results were correlated with clinically assessed disease activity. Fluctuations occurred in the number of T lymphocytes (Leu 1+) and cells with the helper/inducer phenotype (Leu 3a/OKT4+) in both patients and controls. Fluctuations in the number of cells with the suppressor/cytotoxic (Ts/c) cell phenotype (OKT5, OKT8, Leu 2a+) also occurred. Variations in the relative numbers of cells labeled with all three Ts/c monoclonals did occur, but with OKT5 generally labeling fewer cells than OKT8 or anti-Leu 2a. When findings were correlated with disease activity, OKT5 was a more sensitive gauge of disease activity than either OKT8 or anti-Leu 2a. When peripheral blood lymphocyte subsets were correlated with disease activity, the following patterns were observed: a reduction in the number of Ts/c cells without evidence of clinical disease (four episodes), the development of new symptoms suggestive of an acute relapse but without a reduction in the number of Ts/c cells (two episodes), and a reduction in the number of Ts/c cells associated with acute relapse (two episodes). In the two patients with acute relapse and a reduction in the number of Ts/c cells, clinical disease preceded a reduction in the number of Ts/c cells in 1 patient, whereas the two events occurred simultaneously in the other patient. Taken together, these limited results indicate that in some cases a reduction in the number of Ts/c cells may be the result rather than the cause of disease activity and may represent an epiphenomenon.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0364-5134
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
250-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6232891-Adult,
pubmed-meshheading:6232891-Antibodies, Monoclonal,
pubmed-meshheading:6232891-Female,
pubmed-meshheading:6232891-Humans,
pubmed-meshheading:6232891-Leukocyte Count,
pubmed-meshheading:6232891-Male,
pubmed-meshheading:6232891-Multiple Sclerosis,
pubmed-meshheading:6232891-Phenotype,
pubmed-meshheading:6232891-T-Lymphocytes,
pubmed-meshheading:6232891-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:6232891-T-Lymphocytes, Helper-Inducer,
pubmed-meshheading:6232891-T-Lymphocytes, Regulatory
|
pubmed:year |
1984
|
pubmed:articleTitle |
A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|